These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 30946910)

  • 1. Modulating the gut microbiota and inflammation is involved in the effect of Bupleurum polysaccharides against diabetic nephropathy in mice.
    Feng Y; Weng H; Ling L; Zeng T; Zhang Y; Chen D; Li H
    Int J Biol Macromol; 2019 Jul; 132():1001-1011. PubMed ID: 30946910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bupleurum polysaccharides ameliorated renal injury in diabetic mice associated with suppression of HMGB1-TLR4 signaling.
    Liu ZZ; Weng HB; Zhang LJ; Pan LY; Sun W; Chen HX; Chen MY; Zeng T; Zhang YY; Chen DF; Li H
    Chin J Nat Med; 2019 Sep; 17(9):641-649. PubMed ID: 31526499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cordyceps cicadae polysaccharides ameliorated renal interstitial fibrosis in diabetic nephropathy rats by repressing inflammation and modulating gut microbiota dysbiosis.
    Yang J; Dong H; Wang Y; Jiang Y; Zhang W; Lu Y; Chen Y; Chen L
    Int J Biol Macromol; 2020 Nov; 163():442-456. PubMed ID: 32592781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tangshen formula modulates gut Microbiota and reduces gut-derived toxins in diabetic nephropathy rats.
    Zhao T; Zhang H; Yin X; Zhao H; Ma L; Yan M; Peng L; Wang Q; Dong X; Li P
    Biomed Pharmacother; 2020 Sep; 129():110325. PubMed ID: 32535383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. QiDiTangShen granules modulated the gut microbiome composition and improved bile acid profiles in a mouse model of diabetic nephropathy.
    Wei H; Wang L; An Z; Xie H; Liu W; Du Q; Guo Y; Wu X; Li S; Shi Y; Zhang X; Liu H
    Biomed Pharmacother; 2021 Jan; 133():111061. PubMed ID: 33378964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polysaccharides from Armillariella tabescens mycelia ameliorate renal damage in type 2 diabetic mice.
    Yang R; Li Y; Mehmood S; Yan C; Huang Y; Cai J; Ji J; Pan W; Zhang W; Chen Y
    Int J Biol Macromol; 2020 Nov; 162():1682-1691. PubMed ID: 32758603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The potential role of the gut microbiota in modulating renal function in experimental diabetic nephropathy murine models established in same environment.
    Li Y; Su X; Gao Y; Lv C; Gao Z; Liu Y; Wang Y; Li S; Wang Z
    Biochim Biophys Acta Mol Basis Dis; 2020 Jun; 1866(6):165764. PubMed ID: 32169506
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Zhou Q; Yang F; Li Z; Qu Q; Zhao C; Liu X; Yang P; Han L; Shi Y; Shi X
    J Med Microbiol; 2022 May; 71(5):. PubMed ID: 35617337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fucoidan Improves Early Stage Diabetic Nephropathy via the Gut Microbiota-Mitochondria Axis in High-Fat Diet-Induced Diabetic Mice.
    Zhong Z; Zhang Y; Wei Y; Li X; Ren L; Li Y; Zhang X; Chen C; Yin X; Liu R; Wang Q
    J Agric Food Chem; 2024 May; 72(17):9755-9767. PubMed ID: 38635872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sanziguben polysaccharides improve diabetic nephropathy in mice by regulating gut microbiota to inhibit the TLR4/NF-κB/NLRP3 signalling pathway.
    Wang F; Liu C; Ren L; Li Y; Yang H; Yu Y; Xu W
    Pharm Biol; 2023 Dec; 61(1):427-436. PubMed ID: 36772833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Corn silk polysaccharides attenuate diabetic nephropathy through restoration of the gut microbial ecosystem and metabolic homeostasis.
    Dong W; Zhao Y; Li X; Huo J; Wang W
    Front Endocrinol (Lausanne); 2023; 14():1232132. PubMed ID: 38111708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic Effects of Bupleurum Polysaccharides in Streptozotocin Induced Diabetic Mice.
    Pan L; Weng H; Li H; Liu Z; Xu Y; Zhou C; Lu X; Su X; Zhang Y; Chen D
    PLoS One; 2015; 10(7):e0133212. PubMed ID: 26176625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dysbiosis of intestinal microbiota mediates tubulointerstitial injury in diabetic nephropathy via the disruption of cholesterol homeostasis.
    Hu ZB; Lu J; Chen PP; Lu CC; Zhang JX; Li XQ; Yuan BY; Huang SJ; Ruan XZ; Liu BC; Ma KL
    Theranostics; 2020; 10(6):2803-2816. PubMed ID: 32194836
    [No Abstract]   [Full Text] [Related]  

  • 14. Magnesium lithospermate B improves the gut microbiome and bile acid metabolic profiles in a mouse model of diabetic nephropathy.
    Zhao J; Zhang QL; Shen JH; Wang K; Liu J
    Acta Pharmacol Sin; 2019 Apr; 40(4):507-513. PubMed ID: 29941869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resveratrol improves diabetic kidney disease by modulating the gut microbiota-short chain fatty acids axis in
    Yan H; Zhang Y; Lin X; Huang J; Zhang F; Chen C; Ren H; Zheng S; Yang J; Hui S
    Int J Food Sci Nutr; 2024 May; 75(3):264-276. PubMed ID: 38238900
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Liu W; Xu S; Zhang B; Sun X
    Nutrients; 2024 Jul; 16(14):. PubMed ID: 39064789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Compound polysaccharides ameliorate experimental colitis by modulating gut microbiota composition and function.
    Cai Y; Liu W; Lin Y; Zhang S; Zou B; Xiao D; Lin L; Zhong Y; Zheng H; Liao Q; Xie Z
    J Gastroenterol Hepatol; 2019 Sep; 34(9):1554-1562. PubMed ID: 30589960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lycoperoside H protects against diabetic nephropathy via alteration of gut microbiota and inflammation.
    Zhang Z; Li Q; Liu F; Wang D
    J Biochem Mol Toxicol; 2022 Dec; 36(12):e23216. PubMed ID: 36156833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gut microbiota dysbiosis-induced activation of the intrarenal renin-angiotensin system is involved in kidney injuries in rat diabetic nephropathy.
    Lu CC; Hu ZB; Wang R; Hong ZH; Lu J; Chen PP; Zhang JX; Li XQ; Yuan BY; Huang SJ; Ruan XZ; Liu BC; Ma KL
    Acta Pharmacol Sin; 2020 Aug; 41(8):1111-1118. PubMed ID: 32203081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Understanding the gut-kidney axis among biopsy-proven diabetic nephropathy, type 2 diabetes mellitus and healthy controls: an analysis of the gut microbiota composition.
    Tao S; Li L; Li L; Liu Y; Ren Q; Shi M; Liu J; Jiang J; Ma H; Huang Z; Xia Z; Pan J; Wei T; Wang Y; Li P; Lan T; Tang X; Zeng X; Lei S; Tang H; Ma L; Fu P
    Acta Diabetol; 2019 May; 56(5):581-592. PubMed ID: 30888537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.